Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology Gets Approval For Multi-Dose Diquafosol Sodium Eye Drops In PRC

July 23 (Reuters) - Essex Bio-Technology Ltd 1061.HK:

APPROVAL TO COMMERCIALISE MULTI-DOSE DIQUAFOSOL SODIUM EYE DROPS IN PRC

APPROVAL FOR UNIT FOR MULTI-DOSE DIQUAFOSOL SODIUM EYE DROPS FROM NMPA

Further company coverage: 1061.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news